Healthcare epidemiology is continuously evolving with the integration of cutting-edge technology. A notable example is the research of Vatsala Rangachar Srinivasa, MPH, a PhD candidate in epidemiology at the University of Pittsburgh. Her groundbreaking work focuses on the genomic epidemiology of respiratory viruses and provides a deeper understanding of how these pathogens move within healthcare facilities. Her endeavors are considerably crucial in the constant battle against respiratory infections in hospitals, an area where infection prevention professionals continuously strive for excellence.
Srinivasa’s research is presented under the umbrella of the Microbial Genomic Epidemiology Laboratory and augmented by the backing of the National Institutes of Health-funded Enhanced Detection System for Health care-Associated Transmission (EDS-HAT). Initially set up to monitor bacterial infections, Srinivasa’s groundbreaking work has expanded its scope to seasonal respiratory viruses and opened a pathway to use genomic surveillance for identifying hospital-acquired transmissions of these pathogens.
This move towards the uncharted territory of sequencing respiratory viruses in hospitals is commendably progressive. Srinivasa’s team tackled four common respiratory viruses across three hospitals, with data gathered from 2017 to 2019. After sequencing roughly 300 specimens, they discovered about 10% were genetically related. More interestingly, over half these cases had identifiable hospital-based epidemiological links. Notably, the remaining cases lacked such identifiable links, hinting at possible undetected sources like visitors or community connections, thereby building a strong case for the worth of genomic surveillance.
However, like any study, Srinivasa’s research had its limitations. Given the study relied on retrospective data, it couldn’t delve into the real-time transmission dynamics, staff sickness, or how changes in infection control protocols during the COVID-19 pandemic may have influenced the spread. Additionally, the research focused only on infections diagnosed three days or more into a hospital stay, leaving out infections that may have occurred earlier in the stay.
Despite these limitations, the research holds promise for advancing infection prevention. While whole genome sequencing for viral surveillance isn’t a standard practice in many hospitals, Srinivasa’s work can potentially shift this paradigm by highlighting the benefits of genomic surveillance in tracing virus transmission. This could ultimately support early detection and the refinement of infection prevention strategies, even though challenges remain, particularly the complexity, cost and time required for viral sequencing. As she and her team continue to refine their protocols and validate their findings, we can look forward with anticipation to further developments in this field.